Charlotte’s Web Snares Abacus, CEO Looks Forward To ‘$10B Market Opportunity’ Benzinga … Continue reading →
Charlotte’s Web Snares Abacus, CEO Looks Forward To ‘$10B Market Opportunity’ – Benzinga Read More »
Bionano Genomics Reports First Quarter 2020 Financial Results and Provides Business Update GlobeNewswire … Continue reading →
The Daily Biotech Pulse: Eloxx Resumes Cystic Fibrosis Study, Rexahn’s Reverse Merger, Ultragenyx, Epizyme Await FDA Decisions Benzinga … Continue reading →
Form S-1/A Kaleyra, Inc. StreetInsider.com … Continue reading →
Form S-1/A Kaleyra, Inc. – StreetInsider.com Read More »
BRIEF-Iveric Bio Inc Announces Pricing Of Upsized Public Offering Of Common Stock at $4.100 Per Share Reuters … Continue reading →
IVERIC bio, Inc. Announces Pricing of Upsized Public Offering of Common Stock and Pre-Funded Warrants Business Wire … Continue reading →
Rexahn and Ocuphire Enter into Definitive Merger Agreement GlobeNewswire … Continue reading →
Rexahn and Ocuphire Enter into Definitive Merger Agreement – GlobeNewswire Read More »
BRIEF-Rexahn Says Co And Ocuphire Enter Into Definitive Merger Agreement Reuters … Continue reading →
BRIEF-Rexahn Says Co And Ocuphire Enter Into Definitive Merger Agreement – Reuters Read More »
VerifyMe Announces Pricing of $10.0 Million Public Offering, Uplisting to NASDAQ and 50-to-1 Reverse Stock Split Benzinga … Continue reading →
VerifyMe Announces Pricing of $10.0 Million Public Offering, Uplisting to NASDAQ and 50-to-1 Reverse Stock Split Stockhouse … Continue reading →
